Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Molecular Imaging and Biology
Published in: Molecular Imaging and Biology 5/2016

Open Access 01-10-2016 | Special Topic

Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15–19, 2016; Tübingen, Germany

Authors: D. L. Bailey, B. J. Pichler, B. Gückel, H. Barthel, A. J. Beer, R. Botnar, R. Gillies, V. Goh, M. Gotthardt, R. J. Hicks, R. Lanzenberger, C. la Fougere, M. Lentschig, S. G. Nekolla, T. Niederdraenk, K. Nikolaou, J. Nuyts, D. Olego, K. Åhlström Riklund, A. Signore, M. Schäfers, V. Sossi, M. Suminski, P. Veit-Haibach, L. Umutlu, M. Wissmeyer, T. Beyer

Published in: Molecular Imaging and Biology | Issue 5/2016

Login to get access

Abstract

This article provides a collaborative perspective of the discussions and conclusions from the fifth international workshop of combined positron emission tomorgraphy (PET)/magnetic resonance imaging (MRI) that was held in Tübingen, Germany, from February 15 to 19, 2016. Specifically, we summarise the second part of the workshop made up of invited presentations from active researchers in the field of PET/MRI and associated fields augmented by round table discussions and dialogue boards with specific topics. This year, this included practical advice as to possible approaches to moving PET/MRI into clinical routine, the use of PET/MRI in brain receptor imaging, in assessing cardiovascular diseases, cancer, infection, and inflammatory diseases. To address perceived challenges still remaining to innovatively integrate PET and MRI system technologies, a dedicated round table session brought together key representatives from industry and academia who were engaged with either the conceptualisation or early adoption of hybrid PET/MRI systems. Discussions during the workshop highlighted that emerging unique applications of PET/MRI such as the ability to provide multi-parametric quantitative and visual information which will enable not only overall disease detection but also disease characterisation would eventually be regarded as compelling arguments for the adoption of PET/MR. However, as indicated by previous workshops, evidence in favour of this observation is only growing slowly, mainly due to the ongoing inability to pool data cohorts from independent trials as well as different systems and sites. The participants emphasised that moving from status quo to status go entails the need to adopt standardised imaging procedures and the readiness to act together prospectively across multiple PET/MRI sites and vendors.
Literature
1.
Bailey DL, Pichler BJ, Guckel B et al (2015) Combined PET/MRI: multi-modality multi-parametric imaging is here: summary report of the 4th international workshop on PET/MR imaging; February 23-27, 2015, Tubingen, Germany. Mol Imaging Biol 17:595–608CrossRefPubMed
2.
Bailey DL, Barthel H, Beyer T et al (2013) Summary report of the first international workshop on PET/MR imaging, March 19-23, 2012, Tubingen, Germany. Mol Imaging Biol 15:361–371CrossRefPubMedPubMedCentral
3.
Bailey DL, Barthel H, Beuthin-Baumann B et al (2014) Combined PET/MR: where are we now? Summary Report of the Second International Workshop on PET/MR Imaging April 8-12, 2013, Tubingen, Germany. Mol Imaging Biol 16:295–310PubMed
4.
Bailey DL, Antoch G, Bartenstein P et al (2015) Combined PET/MR: the real work has just started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tubingen, Germany. Mol Imaging Biol 17(3):297–312
5.
Czernin J, Ta L, Herrmann K (2014) Does PET/MR imaging improve cancer assessments? Literature evidence from more than 900 patients. J Nucl Med 55:59S–62SCrossRefPubMed
6.
Spick C, Herrmann K, Czernin J (2016) 18F-FDG PET/CT and PET/MRI perform equally well in cancer: evidence from studies on more than 2,300 patients. J Nucl Med 57:420–430CrossRefPubMed
7.
8.
Johnson LM, Choyke PL, Figg WD, Turkbey B (2014) The role of MRI in prostate cancer active surveillance. BioMed Res Intl 2014:203906CrossRef
9.
Johnson LM, Turkbey B, Figg WD, Choyke PL (2014) Multiparametric MRI in prostate cancer management. Nature Reviews Clin Oncol 11:346–353CrossRef
10.
Johnson LM, Rothwax JT, Turkbey B et al (2014) Multiparametric magnetic resonance imaging of the prostate aids detect lesion progression. J Comput Assist Tomogr 38:565–567CrossRefPubMedPubMedCentral
11.
Hicks RJ, Lau EW (2009) PET/MRI: a different spin from under the rim. Eur J Nucl Med Mol Imaging 36(Suppl 1):S10–14CrossRefPubMed
12.
Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRefPubMed
13.
14.
Sabri O, Becker GA, Meyer PM et al (2015) First-in-human PET quantification study of cerebral alpha4beta2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine. Neuroimage 118:199–208CrossRefPubMed
15.
Sander CY, Hooker JM, Catana C et al (2013) Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI. Proc Natl Acad Sci U S A 110:11169–11174CrossRefPubMedPubMedCentral
16.
Sander CY, Hooker JM, Catana C, Rosen BR, Mandeville JB (2016) Imaging agonist-induced D2/D3 receptor desensitization and internalization in vivo with PET/fMRI. Neuropsychopharmacol 41:1427–1436CrossRef
17.
Ladefoged C, Benoit D, Law I et al (2015) PET/MR attenuation correction in brain imaging using a continuous bone signal derived from UTE. Eur J Nucl Med Mol Imaging Physics 2:A39
18.
Burgos N, Cardoso MJ, Thielemans K et al (2014) Attenuation correction synthesis for hybrid PET-MR scanners: application to brain studies. IEEE Trans Med Imaging 33:2332–2341CrossRefPubMed
19.
Burgos N, Cardoso MJ, Thielemans K et al (2014) Attenuation correction synthesis for hybrid PET-MR scanners: validation for brain study applications. EJNMMI physics 1:A52CrossRefPubMedPubMedCentral
20.
Defrise M, Rezaei A, Nuyts J (2012) Time-of-flight PET data determine the attenuation sinogram up to a constant. Phys Med Biol 57:885–899CrossRefPubMed
21.
Defrise M, Rezaei A, Nuyts J (2014) Transmission-less attenuation correction in time-of-flight PET: analysis of a discrete iterative algorithm. Phys Med Biol 59:1073–1095CrossRefPubMed
22.
Rezaei A, Defrise M, Bal G et al (2012) Simultaneous reconstruction of activity and attenuation in time-of-flight PET. IEEE T Med Imaging 31:2224–2233CrossRef
23.
Rezaei A, Defrise M, Nuyts J (2014) ML-reconstruction for TOF-PET with simultaneous estimation of the attenuation factors. IEEE T Med Imaging 33:1563–1572CrossRef
24.
Zhang K, Herzog H, Mauler J et al (2014) Comparison of cerebral blood flow acquired by simultaneous [15O]water positron emission tomography and arterial spin labeling magnetic resonance imaging. J Cereb Blood Flow Metab 34:1373–1380CrossRefPubMedPubMedCentral
25.
Choi H, Cheon GJ, Kim HJ et al (2016) Gray matter correlates of dopaminergic degeneration in Parkinson’s disease: a hybrid PET/MR study using (18) F-FP-CIT. Hum Brain Mapp 37:1710–1721CrossRefPubMed
26.
Catana C, Drzezga A, Heiss WD, Rosen BR (2012) PET/MRI for neurologic applications. J Nucl Med 53:1916–1925CrossRefPubMed
27.
28.
Riedl V, Bienkowska K, Strobel C et al (2014) Local activity determines functional connectivity in the resting human brain: a simultaneous FDG-PET/fMRI study. J Neurosci 34:6260–6266CrossRefPubMed
29.
Hahn A, Gryglewski G, Nics L, et al. (2016) Quantification of task-specific glucose metabolism with constant infusion of [18F]FDG. J Nucl Med 57:(In Press).
30.
31.
Normandin MD, Schiffer WK, Morris ED (2012) A linear model for estimation of neurotransmitter response profiles from dynamic PET data. Neuroimage 59:2689–2699CrossRefPubMed
32.
Normandin MD, Koeppe RA, Morris ED (2012) Selection of weighting factors for quantification of PET radioligand binding using simplified reference tissue models with noisy input functions. Phys Med Biol 57:609–629CrossRefPubMedCentral
33.
34.
Moon JC, Messroghli DR, Kellman P et al (2013) Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15:92CrossRefPubMedPubMedCentral
35.
36.
LaForest R, Woodard PK, Gropler RJ (2016) Cardiovascular PET/MRI: challenges and opportunities. Cardiol Clinics 34:25–35CrossRef
37.
Grimm R, Furst S, Souvatzoglou M et al (2015) Self-gated MRI motion modeling for respiratory motion compensation in integrated PET/MRI. Medical Image Anal 19:110–120CrossRef
38.
Skeoch S, Williams H, Cristinacce P et al (2015) Evaluation of carotid plaque inflammation in patients with active rheumatoid arthritis using (18)F-fluorodeoxyglucose PET-CT and MRI: a pilot study. Lancet 385 Suppl 1:S91CrossRefPubMed
39.
Li X, Heber D, Rausch I et al (2016) Quantitative assessment of atherosclerotic plaques on F-FDG PET/MRI: comparison with a PET/CT hybrid system. Eur J Nucl Med Mol Imaging 43:1503–1512
40.
de Haan S, Rijnierse MT, Harms HJ et al (2015) Myocardial denervation coincides with scar heterogeneity in ischemic cardiomyopathy: a PET and CMR study. J Nucl Cardiol DOI. doi:10.​1007/​s12350-015-0316-z
41.
Dweck MR, Puntman V, Vesey AT, Fayad ZA, Nagel E (2016) MR imaging of coronary arteries and plaques. JACC Cardiovasc Imaging 9:306–316CrossRefPubMed
42.
Rischpler C, Dirschinger RJ, Nekolla SG et al (2016) Prospective evaluation of 18F-fluorodeoxyglucose uptake in postischemic myocardium by simultaneous positron emission tomography/magnetic resonance imaging as a prognostic marker of functional outcome. Circ Cardiovasc Imaging 9, e004316PubMed
43.
Rischpler C, Nekolla SG, Kossmann H et al (2016) Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI. J Nucl Cardiol 23:131–133CrossRefPubMed
44.
45.
46.
Binse I, Poeppel TD, Ruhlmann M et al (2016) Imaging with (124)I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT? Eur J Nucl Med Mol Imaging 43:1011–1017CrossRefPubMed
47.
Vrachimis A, Burg MC, Wenning C et al (2016) [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 43:212–220CrossRef
48.
Sawicki LM, Grueneisen J, Schaarschmidt BM et al (2016) Evaluation of (18)F-FDG PET/MRI, (18)F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer. Eur J Radiol 85:459–465CrossRefPubMed
49.
Grueneisen J, Nagarajah J, Buchbender C et al (2015) Positron emission tomography/magnetic resonance imaging for local tumor staging in patients with primary breast cancer: a comparison with positron emission tomography/computed tomography and magnetic resonance imaging. Invest Radiol 50:505–513CrossRefPubMed
50.
Schaarschmidt BM, Heusch P, Buchbender C et al (2016) Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI. Eur J Nucl Med Mol Imaging 43:92–102CrossRefPubMed
51.
Freitag MT, Radtke JP, Hadaschik BA et al (2016) Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer. Eur J Nucl Med Mol Imaging 43:70–83CrossRefPubMed
52.
Lee DH, Kim SH, Im SA, Oh DY, Kim TY, Han JK (2015) Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study. Eur Radiol 26:2771–2778
53.
54.
Catalano OA, Gee MS, Nicolai E et al (2016) Evaluation of quantitative PET/MR enterography biomarkers for discrimination of inflammatory strictures from fibrotic strictures in Crohn disease. Radiology 278:792–800CrossRefPubMed
55.
Pellino G, Nicolai E, Catalano OA et al (2016) PET/MR versus PET/CT imaging: impact on the clinical management of small-bowel Crohn’s disease. J Crohns Colitis 10:277–285CrossRefPubMed
56.
Chaudhari AJ, Bowen SL, Burkett GW et al (2010) High-resolution (18)F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis. Eur J Nucl Med Mol Imaging 37:1047CrossRefPubMedPubMedCentral
57.
Signore A, Capriotti G, Chianelli M et al (2015) Detection of insulitis by pancreatic scintigraphy with 99mTc-labeled IL-2 and MRI in patients with LADA (Action LADA 10). Diabetes Care 38:652–658PubMed
58.
Glaudemans AW, Quintero AM, Signore A (2012) PET/MRI in infectious and inflammatory diseases: will it be a useful improvement? Eur J Nucl Med Mol Imaging 39:745–749CrossRefPubMedPubMedCentral
59.
Di Gialleonardo V, Signore A, Glaudemans AW, Dierckx RA, De Vries EF (2012) N-(4-18F-fluorobenzoyl)interleukin-2 for PET of human-activated T lymphocytes. J Nucl Med 53:679–686CrossRefPubMed
60.
Malmberg C, Ripa RS, Johnbeck CB et al (2015) 64Cu-DOTATATE for noninvasive assessment of atherosclerosis in large arteries and its correlation with risk factors: head-to-head comparison with 68Ga-DOTATOC in 60 patients. J Nucl Med 56:1895–1900CrossRefPubMed
61.
Vag T, Gerngross C, Herhaus P et al (2016) First experience with chemokine receptor CXCR4-targeted PET imaging of patients with solid cancers. J Nucl Med 57:741–746CrossRefPubMed
62.
63.
Lloyd MC, Cunningham JJ, Bui MM, Gillies RJ, Brown JS, Gatenby RA (2016) Darwinian dynamics of intratumoral heterogeneity: not solely random mutations but also variable environmental selection forces. Cancer Res 76:3136–3144
64.
Tafreshi NK, Lloyd MC, Proemsey JB et al (2016) Evaluation of CAIX and CAXII expression in breast cancer at varied O2 levels: CAIX is the superior surrogate imaging biomarker of tumor hypoxia. Mol Imaging Biol 18:219–231CrossRefPubMed
65.
Gotthardt M, Eizirik DL, Cnop M, Brom M (2014) Beta cell imaging—a key tool in optimized diabetes prevention and treatment. Trends Endocrinol Metab 25:375–377CrossRefPubMed
66.
Eriksson O, Laughlin M, Brom M et al (2016) In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use. Diabetologia 59:1340–1349
67.
Mikkola K, Yim CB, Fagerholm V et al (2014) 64Cu- and 68Ga-labelled [Nle(14), Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats. Mol Imaging Biol 16:255–263CrossRefPubMed
68.
Kalff V, Hicks RJ, MacManus MP et al (2001) Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J Clin Oncol 19:111–118PubMed
69.
Hicks RJ, Kalff V, MacManus MP et al (2001) The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification. J Nucl Med 42:1605–1613PubMed
70.
Hillner BE, Liu D, Coleman RE et al (2007) The National Oncologic PET Registry (NOPR): design and analysis plan. J Nucl Med 48:1901–1908CrossRefPubMed
71.
Hofman MS, Hicks RJ (2015) Moving beyond “lumpology”: PET/CT imaging of pheochromocytoma and paraganglioma. Clin Cancer Res 21:3815–3817CrossRefPubMed
Metadata
Title
Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15–19, 2016; Tübingen, Germany
Authors
D. L. Bailey
B. J. Pichler
B. Gückel
H. Barthel
A. J. Beer
R. Botnar
R. Gillies
V. Goh
M. Gotthardt
R. J. Hicks
R. Lanzenberger
C. la Fougere
M. Lentschig
S. G. Nekolla
T. Niederdraenk
K. Nikolaou
J. Nuyts
D. Olego
K. Åhlström Riklund
A. Signore
M. Schäfers
V. Sossi
M. Suminski
P. Veit-Haibach
L. Umutlu
M. Wissmeyer
T. Beyer
Publication date
01-10-2016
Publisher
Springer US
Published in
Molecular Imaging and Biology / Issue 5/2016
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-016-0993-2

Other articles of this Issue 5/2016

Molecular Imaging and Biology 5/2016 Go to the issue

Research Article

Improvements in PET Image Quality in Time of Flight (TOF) Simultaneous PET/MRI

Research Article

Preclinical Evaluation of an Anti-Nectin-4 ImmunoPET Reagent in Tumor-Bearing Mice and Biodistribution Studies in Cynomolgus Monkeys

Research Article

Cellular Uptake and Intra-Organ Biodistribution of Functionalized Silica-Coated Gold Nanorods

Research Article

PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis

Research Article

Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation

Research Article

Longitudinal Changes in Glucose Metabolism of Denervated Muscle after Complete Peripheral Nerve Injury